[go: up one dir, main page]

DK0502997T3 - Behandling af atopiske sygdomme med gamma-interferon - Google Patents

Behandling af atopiske sygdomme med gamma-interferon

Info

Publication number
DK0502997T3
DK0502997T3 DK91901503.2T DK91901503T DK0502997T3 DK 0502997 T3 DK0502997 T3 DK 0502997T3 DK 91901503 T DK91901503 T DK 91901503T DK 0502997 T3 DK0502997 T3 DK 0502997T3
Authority
DK
Denmark
Prior art keywords
gamma interferon
treatment
atopic diseases
atopic dermatitis
treating patients
Prior art date
Application number
DK91901503.2T
Other languages
English (en)
Inventor
Donald Y M Leung
Raif S Geha
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23766250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0502997(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Application granted granted Critical
Publication of DK0502997T3 publication Critical patent/DK0502997T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91901503.2T 1989-12-01 1990-11-29 Behandling af atopiske sygdomme med gamma-interferon DK0502997T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44476389A 1989-12-01 1989-12-01

Publications (1)

Publication Number Publication Date
DK0502997T3 true DK0502997T3 (da) 1995-07-17

Family

ID=23766250

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91901503.2T DK0502997T3 (da) 1989-12-01 1990-11-29 Behandling af atopiske sygdomme med gamma-interferon

Country Status (8)

Country Link
EP (1) EP0502997B1 (da)
JP (1) JP2901017B2 (da)
AT (1) ATE121945T1 (da)
CA (1) CA2069870E (da)
DE (1) DE69019163T2 (da)
DK (1) DK0502997T3 (da)
ES (1) ES2071977T3 (da)
WO (1) WO1991007984A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3269125B2 (ja) * 1994-01-28 2002-03-25 東レ株式会社 アトピー性皮膚炎治療薬
US5859000A (en) * 1995-06-07 1999-01-12 University Of Utah Research Foundation Method for reducing mast cell mediated allergic reactions
JP3834084B2 (ja) * 1995-09-07 2006-10-18 第一アスビオファーマ株式会社 痒疹治療剤
AU734887B2 (en) * 1997-03-06 2001-06-28 Toray Industries, Inc. Therapeutic agent and treatment for canine intractable dermatitis
DK1702623T3 (da) 1998-04-02 2009-01-19 Genentech Inc Anvendelse af interferon-gamma til behandling af hjertehypertrofi
JP2003513933A (ja) * 1999-11-10 2003-04-15 モンドバイオテック・ソシエテ・アノニム 喘息治療用インターフェロンガンマ
JP4435465B2 (ja) * 2002-08-05 2010-03-17 長岡 均 抗アレルギー剤
EP1430902A1 (en) * 2002-12-20 2004-06-23 Mondobiotech Laboratories Anstalt Pharmaceutical composition of interferon gamma with molecular diagnostics for the improved treatment of asthma bronchiale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
JPH01502980A (ja) * 1986-06-17 1989-10-12 レイチ，スティーブン　デー ガンマインターフェロンと抗炎症剤または抗発熱剤との組合せ並びに疾患処置方法

Also Published As

Publication number Publication date
EP0502997A1 (en) 1992-09-16
DE69019163T2 (de) 1995-09-07
CA2069870A1 (en) 1991-06-02
JP2901017B2 (ja) 1999-06-02
DE69019163D1 (de) 1995-06-08
JPH05501716A (ja) 1993-04-02
ATE121945T1 (de) 1995-05-15
CA2069870C (en) 2000-08-22
CA2069870E (en) 2005-01-11
WO1991007984A1 (en) 1991-06-13
ES2071977T3 (es) 1995-07-01
EP0502997B1 (en) 1995-05-03

Similar Documents

Publication Publication Date Title
DE60018881D1 (de) Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
BR0210231A (pt) Método de controle de uma disfunção relacionada ao fator de crescimento dos nervos (ngf), composição farmacêutica, artigo manufaturado e uso de anticorpo monoclonal anti-ngf
NO883896D0 (no) Konjugater av cytokiner med immunglobuliner.
ATE178487T1 (de) Verwendung von 2-amino-4-(4-fluorbenzylamino)-1- ethoxycarbonylaminobenzen zur prophylaxe und behandlung der folgen der akuten und chronischen zerebralen minderdurchblutung sowie neurodegenerativer erkrankungen
DK0502997T3 (da) Behandling af atopiske sygdomme med gamma-interferon
RU93004982A (ru) Способ лечения эндотоксинового шока с применением антиадгезивных антител
ATE481135T1 (de) Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
ES2054667T3 (es) Anticuerpos monoclonales contra c5a y des-arg74-c5a, su produccion y uso.
FR2710812B1 (fr) Procédé et installation pour le traitement des semences et des bulbes.
EP0270690A4 (en) MEDICINES FOR THE TREATMENT AND PROPHYLAXIS OF LIVER AND KIDNEY DISEASES.
DE3587681D1 (de) Vakzine und Serum für Endotoxin assoziierte Krankheit und Verfahren zur Herstellung derselben sowie Verfahren zur Immunisierung und Behandlung solcher Krankheiten, enttoxifierte Endotoxine und bakterielle Mutante.
BR0314713A (pt) Processos e reagentes para o tratamento de doenças e distúrbios associados com nìveis aumentados de citocinas pró-inflamatórias
DE3650505D1 (de) AICA riboside zur prophylaktischen Behandlung von Krankheiten mit einer verminderten Durchblutung.
BR9612234A (pt) Composto processo para preparação do mesmo uso do composto e processos para tratamento de doenças das vias aéreas e tratamento ou profilaxia de glaucoma
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
Warren The control of helminths: nonreplicating infectious agents of man
DK0435153T3 (da) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, fremgangsmåde til dens fremstilling og lægemidler med indhold deraf
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
BR9008011A (pt) Processo de tratamento por estiramento de cada fibra individual de qualquer tipo
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
DE69109314D1 (de) Humaner monoklonaler Antikörper und diesen enthaltende Arzneimittelzusammensetzung zur Behandlung von Pseudomonasinfektionen.
DE3681428D1 (de) Stoerungen von karbohydraten in viren oder virusantigenen und verwendung in diagnostischen, prophylaktischen und/oder therapeutischen anwendungen.
DE3878529D1 (de) Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen.
ES2117008T3 (es) Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.